Concepedia

Joshua A. Levine

JA

10

Publications

380

Citations

10

H-Index

2004

Active since

Affiliations

Eli Lilly (United States)(Current)

Northwestern University

Trillium Health Centre

Eli Lilly (Ireland)

Jesse Brown VA Medical Center

Joshua A. Levine is an author at Eli Lilly (United States) specializing in cell signaling, self-tolerance, and natural killer cells.

ORCID

Top concepts

Publications per year

2004–2023

10

Publications

10

Role of PAI-1 in hepatic steatosis and dyslipidemia

Joshua A. Levine, Carlota Oleaga, Mesut Eren et al. · Scientific Reports · 2021 · 101 citations · Full text

High‐resolution NMR spectroscopic trends and assignment rules of metal‐free, metallated and substituted corroles

Yael S. Balazs, Irena Saltsman, Atif Mahammed et al. · Magnetic Resonance in Chemistry · 2004 · 76 citations

Efficacy of tirzepatide 5, 10 and 15 mg versus semaglutide 2 mg in patients with type 2 diabetes: An adjusted indirect treatment comparison

Karan Vadher, Hiren Patel, Reema Mody et al. · Diabetes Obesity and Metabolism · 2022 · 51 citations · Full text

Predictors of ≥15% Weight Reduction and Associated Changes in Cardiometabolic Risk Factors With Tirzepatide in Adults With Type 2 Diabetes in SURPASS 1–4

Maciej T. Małecki, Rachel L. Batterham, Naveed Sattar et al. · Diabetes Care · 2023 · 43 citations · Full text

Prenatal Androgen Treatment Alters Body Composition and Glucose Homeostasis in Male Rats

Miloš Lazić, Fraser Aird, Joshua A. Levine et al. · Journal of Endocrinology · 2010 · 31 citations · Full text

Rows per page

1–5 of 10